Filing Details

Accession Number:
0001209191-14-016958
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-04 20:01:25
Reporting Period:
2014-03-02
Filing Date:
2014-03-04
Accepted Time:
2014-03-04 20:01:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
69499 Mylan Inc. MYL Pharmaceutical Preparations (2834) 251211621
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1534275 Anthony Mauro 1000 Mylan Blvd
Canonsburg PA 15317
President, North America No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-03-02 1,269 $0.00 22,188 No 4 M Direct
Common Stock Disposition 2014-03-02 400 $55.57 21,788 No 4 F Direct
Common Stock Acquisiton 2014-03-02 5,379 $0.00 27,167 No 4 M Direct
Common Stock Disposition 2014-03-02 1,694 $55.57 25,473 No 4 F Direct
Common Stock Acquisiton 2014-03-03 20,000 $23.44 45,473 No 4 M Direct
Common Stock Disposition 2014-03-03 20,000 $54.81 25,473 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2014-03-02 1,269 $0.00 1,269 $0.00
Common Stock Performance Restricted Stock Units Disposition 2014-03-02 5,379 $0.00 5,379 $0.00
Common Stock Stock Option Right to Buy Disposition 2014-03-03 20,000 $0.00 20,000 $23.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
0 No 4 M Direct
14,698 2022-02-22 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,574 Indirect By 401(k) Plan
Footnotes
  1. Represents withholding of shares for the tax liability associated with the vesting of a portion of the restricted stock units (RSUs) granted on March 2, 2011.
  2. Represents withholding of shares for the tax liability associated with the vesting of the performance restricted stock units (PRSUs) granted on March 2, 2011.
  3. Represents the weighted average price of the reporting person's disposition of shares in transactions ranging from $54.80 to $54.85.
  4. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 3 to this Form 4.
  5. Each RSU represents the right to receive one share of Mylan Inc. common stock. The award fully vested on March 2, 2014.
  6. Each PRSU represents the right to receive one share of Mylan Inc. common stock. The PRSUs were initially granted on March 2, 2011, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs fully vested on March 2, 2014.
  7. Two-thirds of the options vested in equal installments on February 22, 2013 and 2014. The remainder of the options will vest on February 22, 2015.